Connect with us

Cannabis News

If the FDA is Incapable of Providing Guidance on CBD, Why Do We Even Have an FDA at All?



fda on cbd regs

The FDA, or the Food and Drug Administration, has long been touted as the guardian of public health, responsible for regulating everything from the drugs we take to the food we eat. But the reality is far from what it seems. Time and time again, the FDA has shown itself to be an inept and unreliable organization, one that is more concerned with serving the interests of Big Pharma than the well-being of the American people.


Let’s take a walk down memory lane, shall we? The FDA approved Thalidomide, a morning sickness drug that caused birth defects, in the 1950s and 60s. The disaster was only discovered after it was too late, causing widespread harm to countless families. Fast forward to the 90s, the FDA approved Vioxx, a painkiller that was later found to cause heart attacks and strokes. These are just two examples of the many times the FDA has dropped the ball, putting profits before people.


But it’s not just a matter of historical failures. The FDA’s track record in recent years is just as concerning. They’ve been slow to approve safe and effective drugs like medical marijuana, while fast-tracking dangerous and ineffective drugs like OxyContin. The opioid epidemic that has ravaged America in recent years is largely the result of the FDA’s incompetence and indifference.


In the words of Robert Anton Wilson, “the universe is a cosmic joke played on us by a universal sense of humor.” And the FDA is no exception. Its inability to effectively regulate the products that we put into our bodies is a testament to the absurdity of our world.


In conclusion, the FDA’s history of approving dangerous drugs, blocking safe and effective treatments, and prioritizing profits over people, is a clear indication of their ineptitude.


One of their recent failures comes in the form of “passing the buck” to Congress in relation to providing clear regulations on CBD.


What this means is that for now, everything will remain “as is” and now Congress will have to begin deliberation on what the type of regulation would be. But isn’t it the job of the FDA to provide those regulations?


If this is all sounding odd to you, don’t worry – it is!


The FDA has long been a critical part on maintaining the War on Drugs by playing the “Catch-22 of the DEA and the FDA”. In other words, when someone in the public asks the DEA to reschedule any drug in Schedule I, they would say that first they would need a report from the FDA.


Going to the FDA, the will tell you – certainly! We just need some permissions from the DEA. So you’re back at the DEA and say, “So the FDA told me I need something from you so they can give me access…and the DEA says, “Not a problem! We just need a few studies from the FDA in order to give you those permissions…”


And then you realize that the War on Drugs was a corporate power play that essentially monopolized all drug manufacturing and distribution in the hands of a few mega corps.




The point is, that the whole system is created so that it’s insanely difficult to legalize any drug that would cut into the profit margins of Big Pharma, and those who dare to even attempt this will be met with Blackhawk helicopters and paramilitary units.



According to MJBizDaily, the reason why the FDA doesn’t want to touch CBD is because it’s linked to the 2018 Farm Bill, that legalized Hemp. They argue that Congress would have to renegotiate that bill in order for them to be able to do any regulatory oversight.


And to be fair, they aren’t wrong either. The FDA can’t change laws, only Congress can. The 2018 Farm Bill made things like Delta-8 legal as long as its derived from Hemp.


Therefore, even if the FDA says anything about it, they won’t be able to do anything about it.


Here’s a snippet from the MJBizDaily Article


A massive piece of legislation that covers farm subsidies, food-stamp benefits and many other topics, the 2018 Farm Bill – promoted by then-Senate Majority Leader Mitch McConnell and signed into law by former President Donald Trump –  legalized hemp production nationwide.


In so doing, it also predicated the CBD boom and, along with it, the rise of novel intoxicating cannabinoids derived from hemp.


Since that time, the FDA has been on notice to figure out how to regulate an onslaught of products containing CBD and other cannabinoids derived from hemp.

Rather than do that, the FDA declined Thursday to regulate CBD products including other food supplements, saying its existing regulatory frameworks were inadequate – and that Congress should tell the FDA what to do.


In a statement Thursday, Dr. Janet Woodcock, the FDA’s principal deputy commissioner, said the agency “has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”

“The use of CBD raises various safety concerns, especially with long-term use,” Woodcock added.

“The agency is prepared to work with Congress on this matter.”

Though Woodcock did not mention other cannabinoids that have gained popularity over the past four years – including delta-8 and delta-10 THC, which can be derived from CBD via a chemical process, as well as delta-9 THC – the FDA has noted the “serious health risks” posed by so-called alternative cannabinoids and has been tracking reports of adverse health effects.


 In other words, it took them 4-years to say that they don’t have the tools or parameters to do the work needed. 4 YEARS!!!!


Yet, along roles a “pandemic” with a virus of 99.6% survivability and they can approve booster after booster in a matter of months…


I wonder why they can approve Pharma’s drugs in a matter of months but are incapable of telling Congress “they can’t regulate CBD” for 4-years!



The idea that marijuana could reduce Big Pharma’s revenues is an age-old one, and it is a classic example of the little guy defeating the big bully. It’s a tale that has often been told in the pages of American history, and it’s an one that is currently being written in the world of medical treatment.


The people at Big Pharma have been making a killing for years by marketing various medicines and potions that claim to be able to treat all of your ailments. But now that this wild card, this rebel force, this green threat has entered the picture, their earnings are suddenly in peril.



Cannabis is a potent medication that has been used for treating a variety of diseases for thousands of years. It is a natural treatment that has repeatedly been shown to be successful in treating a variety of diseases, including pain, anxiety, and depression. Furthermore, it is a treatment that is easily accessible to everyone who seeks it.


How does this affect Big Pharma’s bottom line, then? Simple. Big Pharma’s profits decline if people use cannabis instead of their proprietary medications. And that bothers them a great deal.


Big Pharma, you see, is a complicated web of interests with ties to both the highest echelons of government and the shadowy underbelly of the economy. It is not just some faceless corporation. It’s a huge conspiracy, one that’s out to crush the underdog and preserve a tight grip on the market.


But things are changing. People are becoming more aware of the advantages of cannabis and are demanding access to it. And even the largest firms are forced to pay attention when the public demands something.


However, these businesses continue to hold a majority of the market thanks to strategies and practices like “passing the buck” by the FDA.


The truth is that every time cannabis is legalized, Pharma loses billions. Millions of individuals could benefit from CBD, which is a truly wonderful material. However, because it is currently in a legal “limbo,” it cannot be widely dispersed, and investors are wary of making purchases on the assumption that “what if the government decides it’s bad again?”


This is also the main justification for why marijuana is still illegal in the US.


My friends, it’s time for the populace to advance past the government. We have been held hostage by a system that has been bought and paid for by the very industries it is meant to control for far too long. The government has evolved into a tool of the oppressors, used to keep the populace under control and in line.


Consider Big Pharma as an example. They have dirty hands in every pie, and they purchase politicians’ and regulators’ support with their influence and power. What do they get in return for this? a carte blanche to act however they choose, to push their medications and therapies on a gullible populace, and to extort them for everything they’re worth.


What about the FDA, then? The very organization tasked with keeping us secure has failed miserably. They are so deeply entwined with Big Pharma that they are unable to control the regulation of something as basic and natural as CBD. They have refused to acknowledge this remarkable plant and have chosen to ignore the numerous studies that demonstrate its advantages.


Folks, this is the current status of our government. We are dealing with a dysfunctional system here. It’s time for us to move past it, to liberate ourselves from its bonds, and to take charge of our own lives.


I’d say Robert Anton Wilson is one of my heroes. He had a unique perspective on the world and was a true rebel. He was aware that reality is dynamic and that our perceptions and beliefs may influence it. He also showed us that the only way to change the world is to alter our perspective on it.


Therefore, that is what we must do. We need to abandon the outdated paradigms and adopt a fresh perspective that is built on liberty, autonomy, and self-determination. In order to create a new route that is driven by our own ambitions and objectives, we must reject the conventional methods of doing things.


My friends, it’s time for us to progress past government. It’s time for us to reclaim our freedom and our power. Because we can only change ourselves if we change the world. So let’s take action, unleash the potential of our hearts and brains, and build a new reality free from the constraints of big business and the tyranny of the state.





Source link

Continue Reading

Cannabis News

Minnesota Social Equity Verification: Key Dates Start June 21




The Minnesota cannabis social equity initiative

As Minnesota continues to develop its legal cannabis industry, the Minnesota Office of Cannabis Management (OCM) has taken significant steps to ensure that the process is inclusive and equitable. One of the most notable advancements in this area is the recent update to the social equity application and verification process for cannabis licenses.

This advancement aims to address the harmful societal impacts of the War on Drugs, historical disparities, and ensure that those most affected by cannabis prohibition have the opportunity to participate in the new market. Historically, communities of color and economically disadvantaged groups have been disproportionately affected by cannabis prohibition. Recognizing this, Minnesota has committed to creating a more inclusive industry by providing these groups with enhanced opportunities to obtain cannabis licenses.

Just recently, Minnesota enacted amendments and modifications to their new cannabis law enacting a licensing preapproval and vetted lottery process for qualified social equity applicants. In addition to streamlining the application process, Minnesota has also introduced support services for social equity applicants. These services include business development training, mentorship programs, and access to financial resources. By providing these tools, the state hopes to empower social equity applicants to succeed in the cannabis industry.

Recognizing the importance of awareness and education, the OCM has established a campaign focused on outreach and education regarding the new and ever-evolving regulations surrounding cannabis licensing. These initiatives aim to inform potential applicants about the benefits of social equity verification and guide them through the process. This includes community workshops, online resources, and partnerships with local organizations.

Minnesota social equity verification requirements

Beginning on Monday, June 24, 2024, the OCM will begin the verification process for qualified individuals who want to be pre-approved for cannabis licenses.

Broadly speaking, to qualify for a social equity cannabis license under Minnesota regulations, an applicant must have been convicted of cannabis possession or sale, be a military veteran, or have worked for a farming operation. These specific requirements are explained in more detail below and can be found on the OCM website here with the required documentation for each category:

  1. The applicant was convicted of an offense involving the possession or sale of cannabis prior to May 1, 2023;
  2. The applicant had a parent, guardian, child, spouse, or dependent convicted of an offense involving the possession or sale of cannabis prior to May 1, 2023;
  3. The applicant was a dependent of someone convicted of an offense involving the possession or sale of cannabis prior to May 1, 2023;
  4. The applicant is a military veteran, including service-disabled veterans, or current/former members of the National Guard;
  5. The applicant is a military veteran or National Guard member who lost honorable status due to an offense involving the possession or sale of cannabis;
  6. The applicant has been a resident for the past five years in an area with:
    1. High cannabis enforcement rates as determined by federal or state studies or data;
    2. A poverty rate of 20% or more;
    3. Median family income not exceeding 80% of the statewide median family income;
    4. At least 20% of households receiving Supplemental Nutrition Assistance Program (SNAP) assistance; or
    5. Populations that experienced a high level of vulnerability, according to the Centers for Disease Control and Prevention’s Social Vulnerability Index; or
  7. The applicant has participated in farm operations for at least three years, providing the majority of day-to-day labor and management on a farm with gross sales between $5,000 and $100,000 in the previous year.

Key upcoming dates for Minnesota social equity applicants

On June 21, 2024, the OCM will host a training workshop from 4-6 pm at Sabathani Community Center Auditorium located at 310 E 38th St. Ste. 200, Minneapolis, Minnesota 55409. Participants for the training can register here. For anyone unable to attend in person, the OCM will publish another recording on its website providing an outline of the verification process.

On June 24, 2024, the OCM will open the social equity verification process allowing participants to ensure they meet the social equity requirements. This process will end on July 10, 2024.

On July 24, 2024, those applicants that were verified as social equity applicants will be able to submit an application for cannabis license preapproval. Those license applications will then go through review and a vetting process and will be entered into a lottery to be held later this fall. This preapproval process window will close on August 12, 2024.


The OCM is moving swiftly in order to bring the Minnesota legal cannabis market online. In doing so, they are prioritizing social equity applicants and providing guidance and a preapproval vetting process for those applicants ready to apply. However, this process will require the submission of specific documents and evidence that the applicant meets the criteria set forth above, so it is best if applicants begin reviewing the documentation requirements now. Applicants should then start compiling those documents and getting their applications ready.

Be sure to review the OCM website for additional requirements and resources. They plan to publish additional materials in the coming weeks to assist social equity applicants through the process of obtaining a cannabis license.

Source link

Continue Reading

Cannabis News

Celebrating Juneteenth Today – Canna Law Blog™




Our offices are closed today in commemoration of the Juneteenth holiday. In the past, we’ve used this occasion to highlight the need for criminal justice reform, inside and outside of the cannabis industry.

Juneteenth is also a day of celebration, to commemorate the liberation of enslaved people in the United States.

We hope you have the day off today! And that you have the opportunity to celebrate and reflect on the significance of our newest federal holiday.

We’ll be back tomorrow with our regular programming.

Source link

Continue Reading

Cannabis News

Talking to God and Feeling the Warmth of Your Soul




what is tripping on DMT like

Dimethyltryptamine, or DMT, is a substance with hallucinogenic properties that may be found in a wide range of plants and animals. When taken in large enough quantities, DMT may produce a “high” and cause distortions in one’s senses, making things appear that they aren’t. Other names for it include elven spice, spirit molecule, businessman’s special, and Dimitri.


For ages, people from many cultures have utilized DMT in rituals and religious ceremonies. It is one of the active components in South American psychedelic beverage ayahuasca. Laboratories are also capable of producing synthetic DMT.


Recreational users go for DMT because it produces a strong, brief “trip,” sometimes referred to as a “breakthrough in DMT.” Although some studies point to possible advantages for both physical and mental health, the drug’s adverse effects may offset these advantages.


Some have described tripping on DMT “like dying”, but in a positive way of getting to see the universe and afterlife. Many people feel a deep euphoric feelling that can be humbling, like comparing yourself to a piece of sand in the universe.  In a religious sense, those say you become one with the universe or the “god in you”.




Both DMT and LSD, sometimes known as acid, are potent “psychedelic” substances that can change your perception. Their molecular makeup is identical to that of serotonin, a neurotransmitter found in your brain.


Differences between DMT and acid include:


Source. While LSD is manmade and derived from a material in a fungus that grows on rye grains, DMT is found in both plants and mammals.


Length of time. Whereas an acid trip can last up to 12 hours, DMT is a powerful, short experience lasting 15 to 60 minutes.


How Does DMT Trip Make You Feel?


DMT affects individuals differently, but common effects include:


– Visual or auditory hallucinations

– Out-of-body experiences

– Mood changes

– Heightened sensitivity to physical sensations such as pain, tingling, and warmth

– Feelings of euphoria or intense happiness

– Spiritual and emotional experiences

– Distorted body image

– The ability to unlock hidden memories


The effects of DMT depend on several factors, including:


– Your size, weight, and overall health

– Whether it’s your first time using it or not

– Whether you have taken other substances simultaneously

– The dosage

– The drug’s potency, which can vary between sources

– Your environment

– Your mood at the time of consumption


Set and Setting with DMT


When using DMT, your physical surroundings and mental state are referred to as your “set and setting.” These factors have a big impact on your experience, both good and bad.


The set is the state of mind you are in before using the drug; it includes your feelings, expectations, past psychedelic experiences, and any tension or worries you may be experiencing.


Setting includes the people and things in your immediate surroundings. You may be in a familiar setting with individuals you can trust, or you may be in a foreign area alone. You will be affected differently by a calm, peaceful setting than by a busy, boisterous one.


Can DMT Cause a Bad Trip?


It is possible to have a negative experience, or “bad trip,” when taking DMT. Instead of euphoria, you might feel:


– Intense anxiety

– Frightened by your hallucinations

– Very confused

– Paranoid


Being in a positive set and setting can help reduce the risk of a bad trip.


Due to limited research, the long-term effects of DMT are not well understood. Flashbacks, which can be unpleasant and occur days, weeks, or even months after taking DMT, are a commonly reported side effect.


While there are no reports of toxicity from long-term DMT use, there are concerns about its impact on heart health, as it can raise blood pressure.


Potential Therapeutic Uses of DMT


According to recent studies, DMT may have a variety of medicinal uses. Studies suggest that DMT may be helpful in the treatment of mental health issues, however, they are still in their early phases. Here are a few possible medicinal applications:


1. Treatment for Sadness and Anxiety: According to preliminary studies, DMT can affect mood in a quick and significant way, which may be able to provide treatment for those with sadness and anxiety. Because DMT experiences are strong and brief, they may provide immediate therapeutic effects without requiring lengthy therapy sessions.


2. Support Psychotherapy: People may find it easier to process trauma and unearth suppressed memories if DMT can elicit strong emotional and spiritual experiences. DMT may help make significant progress in psychotherapy under carefully monitored conditions, enabling patients to address and resolve ingrained psychological problems.


3. Potential for Addiction Treatment:

Some studies suggest that DMT and other psychedelics might be useful in treating substance abuse disorders. By providing profound insights and altering perception, DMT could help individuals break free from addictive behaviors and develop healthier coping mechanisms.


4. Neurogenesis and Brain Health: Some research indicates that DMT may encourage neurogenesis, or the development of new neurons, which may have an impact on cognitive performance and overall brain health. Conditions like Alzheimer’s disease and other neurodegenerative illnesses may benefit especially from this feature.


Even while these prospective advantages seem encouraging, it’s crucial to remember that DMT research is still in its early stages. To completely comprehend its therapeutic potential and create safe, efficient treatment procedures, more thorough, controlled research is required. To reduce hazards and optimize benefits, the DMT experience is intense, thus it must be administered in a controlled setting, ideally under the guidance of qualified specialists.


Bottom Line


DMT, or dimethyltryptamine, is a powerful hallucinogenic compound found in various plants and animals and can be synthesized in laboratories. Known by names like elven spice, spirit molecule, businessman’s special, and Dimitri, DMT has been used for centuries in rituals and religious ceremonies, particularly in South American cultures through the ayahuasca brew. Recreational users seek DMT for its intense, short-lived “trip,” which can include profound sensory distortions and out-of-body experiences. The effects of DMT vary greatly depending on factors like dosage, individual health, environment, and mental state. A positive “set and setting” can enhance the experience and reduce the risk of a “bad trip,” characterized by intense anxiety, confusion, and paranoia. Although the long-term effects of DMT are not well understood due to limited research, some studies suggest potential therapeutic benefits, such as treatment for depression, anxiety, and substance abuse disorders. However, these potential benefits come with risks, including the possibility of flashbacks and concerns about heart health due to increased blood pressure. In summary, while DMT offers intriguing possibilities for both recreational and therapeutic use, it should be approached with caution and ideally under professional supervision to mitigate risks and maximize potential benefits.





Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media